Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.95M.
ENTERPRISE VALUE (EV)
$1.95M
Enveric Biosciences, Inc.
Market Cap
$6.62M
Enterprise Value (EV)
$1.95M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.62M | $1.95M |
| Aclarion, Inc. (ACON)vs › | $6.66M | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.49M | $15.26M |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.45M | $5.97M |
| Femasys Inc. (FEMY)vs › | $6.28M | $9.63M |
| Biomerica, Inc. (BMRA)vs › | $6.21M | $6.79M |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.02M | $7.02M |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | $5.21M |
| Mangoceuticals, Inc. (MGRX)vs › | $7.10M | $7.20M |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.05M | $833931.00 |
Market Cap
$6.62M
Total Debt
$0.00
Cash
$4.68M
Enterprise Value
$1.95M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
